The cardinal properties of memory CD8 T cells are rapid elaboration of effector function and the ability to proliferate when they re-encounter a pathogen 1 . Memory cells also persist for extended periods after antigen has been cleared to provide long-term immunity 2 . Indeed, functional virus-specific memory CD8 T cells can be detected in humans for several decades following acute viral infections or immunization with live attenuated vaccines 3,4 . However, fundamental issues about the origin of human memory CD8 T cells, their differentiation and the dynamics of their turnover rate in vivo have not been well defined [5] [6] [7] . In this study, we address these questions by labelling human virus-specific CD8 T cells in vivo with deuterium, and longitudinally tracking the labelled antigen-specific cells as they transition through the naive-toeffector and memory stages of T cell differentiation. We use the highly effective live attenuated YFV vaccine (YFV-17D), which confers longterm immunity in humans and allows us to longitudinally monitor YFV tetramer + CD8 T cells in the blood after vaccination. As there is no YFV circulating in the United States, this vaccine allows us to immunize YFV-naive individuals and characterize a primary human CD8 T cell response to an acute viral infection, and to examine the generation and maintenance of memory CD8 T cells in the absence of subsequent viral re-exposure 8 .
The cardinal properties of memory CD8 T cells are rapid elaboration of effector function and the ability to proliferate when they re-encounter a pathogen 1 . Memory cells also persist for extended periods after antigen has been cleared to provide long-term immunity 2 . Indeed, functional virus-specific memory CD8 T cells can be detected in humans for several decades following acute viral infections or immunization with live attenuated vaccines 3, 4 . However, fundamental issues about the origin of human memory CD8 T cells, their differentiation and the dynamics of their turnover rate in vivo have not been well defined [5] [6] [7] . In this study, we address these questions by labelling human virus-specific CD8 T cells in vivo with deuterium, and longitudinally tracking the labelled antigen-specific cells as they transition through the naive-toeffector and memory stages of T cell differentiation. We use the highly effective live attenuated YFV vaccine (YFV-17D), which confers longterm immunity in humans and allows us to longitudinally monitor YFV tetramer + CD8 T cells in the blood after vaccination. As there is no YFV circulating in the United States, this vaccine allows us to immunize YFV-naive individuals and characterize a primary human CD8 T cell response to an acute viral infection, and to examine the generation and maintenance of memory CD8 T cells in the absence of subsequent viral re-exposure 8 .
Marking virus-specific CD8 T cells with deuterium
We vaccinated individuals who expressed the human leukocyte antigen HLA-A2 and thus had CD8 T cells specific for the HLA-A2 restricted epitope in the NS4b protein (A2-NS4B 214 ) of the virus. In our first deuterium labelling study, vaccinees took heavy water (D 2 O) daily for the first two weeks after YFV-17D vaccination, and their blood was sampled at multiple subsequent time points (study 1; Fig. 1a ). Longitudinal analysis of the frequencies of virus-specific A2-NS4B 214 tetramer + CD8 T cells in this group showed the typical stages of CD8 T cell expansion, contraction and maintenance (Fig. 1b) . At each of the time points indicated, we sorted tetramer + CD8 T cells using fluorescence-activated cell sorting (FACS) and then used gas chromatography-mass spectrometry (GC-MS) to quantify the deuterium content in their DNA (Fig. 1c) as well as in body water samples (body water sampled from plasma or saliva; Extended Data Fig. 1 ). Heavy water was enriched in body water and was subsequently washed out of the system by day 42 after vaccination, consistent with previously reported kinetics [9] [10] [11] [12] . In this study, the D 2 O intake from day 0 to 14 was coincident with the period in which virus-specific CD8 T cells went through robust proliferation; consequently, tetramer + CD8 T cells had incorporated the maximum possible levels of deuterium from the D 2 O enrichment in body water over the two weeks following vaccination. This incorporation of deuterium into the DNA of cells that divided while D 2 O was present can reveal the rate of cell division. The dilution of deuterium in cells following cessation of heavy water intake provides an additional method of measuring the rate of cell division 9, 12 . In this case, the die-away of deuterium over time represents the rate at which labelled virus-specific CD8 T cells divide and incorporate unlabelled DNA strands through cell proliferation. Our analysis of tetramer + CD8 T cells sorted at successive time points over the next 250-750 days showed that deuterium enrichment levels in the YFVspecific CD8 T cells exhibited only slight dilution by newly divided cells (Fig. 1c, Supplementary Table 1 , cell division rate 0.17 ± 0.09% per day) corresponding to a half-life of deuterium enrichment in the The differentiation of human memory CD8 T cells is not well understood. Here we address this issue using the live yellow fever virus (YFV) vaccine, which induces long-term immunity in humans. We used in vivo deuterium labelling to mark CD8 T cells that proliferated in response to the virus and then assessed cellular turnover and longevity by quantifying deuterium dilution kinetics in YFV-specific CD8 T cells using mass spectrometry. This longitudinal analysis showed that the memory pool originates from CD8 T cells that divided extensively during the first two weeks after infection and is maintained by quiescent cells that divide less than once every year (doubling time of over 450 days). Although these long-lived YFV-specific memory CD8 T cells did not express effector molecules, their epigenetic landscape resembled that of effector CD8 T cells. This open chromatin profile at effector genes was maintained in memory CD8 T cells isolated even a decade after vaccination, indicating that these cells retain an epigenetic fingerprint of their effector history and remain poised to respond rapidly upon re-exposure to the pathogen.
tetramer-sorted population that averaged more than a year (493 days) in the period after washout of heavy water. These data establish two notable points. First, the high deuterium enrichment that remains in the YFV-specific memory CD8 T cells 1-2 years after vaccination shows that this population is seeded by T cells that underwent extensive proliferation and were 'marked' by deuterium when they were first generated during the effector stage of the immune response. Second, the surviving YFV-specific memory CD8 T cells exhibit notable proliferative quiescence and have a very long inter-mitotic interval (greater than one year).
Interestingly, the deuterium enrichment in study 1 did not undergo exponential decay in a monophasic fashion but instead showed biphasic dilution kinetics. A sharper decline was observed in the two weeks immediately after the vaccinees discontinued D 2 O intake (die-away rate 1.1 ± 0.7% per day) and a more gradual decline was seen thereafter (0.17 ± 0.09% per day, as noted above) in the second phase of the deuterium die-away curve. To investigate this result, we studied a second group of vaccinees in whom D 2 O intake was initiated 14 days after vaccination and was continued until day 28 (study 2; Fig. 2a) . Tetramer frequencies and D 2 O washout for this group followed the expected kinetics (Extended Data Fig. 2a, 2b) . At the conclusion of heavy water intake at day 28 post-vaccination, deuterium labelling showed that 65.7 ± 14.8% (compared to the maximal proportion of labelled cells seen at the end of day 14 in study 1) of YFV-specific CD8 T cells (Fig. 2b) were newly divided. Most of this proliferation was seen between days 14 and 21, which produced an average of 51.3 ± 18.8% newly divided cells, followed by an increase of another 14.4% between days 21 and 28. This demonstrates that, in addition to the very extensive CD8 T cell expansion that occurs during the first two weeks after . c, Die-away curves of deuterium enrichment after label washout. Data are normalized to maximum label incorporation, seen at day 28 (n = 7). d, Design for study 3. e, The percentage of newly divided A2-NS4B 214 tetramer + CD8 T cells that incorporated deuterium during the D 2 O intake period (shaded blue area) for study 3 (n = 8). f, The cell division rate constants of YFV-specific memory CD8 T cells, calculated either by die-away kinetics of deuterium enrichment (reflecting dilution rates of labelled cells by unlabelled cells; studies 1 and 2) or by kinetics of deuterium uptake (reflecting division rates of labelled cells; study 3). The corresponding T 1/2 of the deuterium enrichment (and hence the division rate of tetramer + memory CD8 T cells) is 493 days (study 1), 460 days (study 2) or 476 days (study 3). Bar graphs show mean and s.e.m.
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vaccination, there is still substantial proliferation between days 14 and 28. Thus, in study 1 (Fig. 1c) , the initial rapid dilution phase of deuterium enrichment (between days 14 and 28) in the DNA of CD8 T cells is explained by the input of new cells arising from continued division after the D 2 O levels in the body had diminished (Extended Data Fig. 1 ). Viraemia was below detectable limits by day 11 (Fig. 1b) , but it is likely that the delayed proliferation seen between days 14 and 28 was driven by residual antigen in the tissues. In study 2, the die-away of deuterium enrichment in YFV-specific memory CD8 T cells that were labelled during days 14-28 after vaccination no longer exhibited an initial phase of more rapid dilution after heavy water intake ceased (Fig. 2c) . This is consistent with the finding from label incorporation that T cell proliferation had slowed considerably by day 28. The subsequent die-away of deuterium enrichment in the DNA of virus-specific CD8 T cells labelled during days 14-28 was now monophasic and extremely slow, with an average T 1/2 of 460 days (Fig. 2c , cell division rate 0.19 ± 0.10 per day). These results again show that, following the initial phase of antigen-driven proliferation, YFV-specific CD8 T cells enter a quiescent phase with a remarkably slow rate of cell division as early as 30 days after vaccination. Even 1-2 years after vaccination, the majority of YFV-specific CD8 T cells present were from the original cohort of cells that had proliferated in the first few weeks in response to the vaccine.
Quantifying memory CD8 T cell half-life in vivo
We next sought to measure directly the in vivo rate of proliferation of resting virus-specific memory CD8 T cells during the maintenance stage of the immune response. In study 3, a new group of HLA-A2 Fig. 2d ). In this study, heavy water intake needed to be continued for a longer duration because of the slow rate of cell proliferation, which we had established on the basis of dilution of deuterium enrichment during the maintenance stage of memory (studies 1 and 2). D 2 O levels in the body water plateaued by day 14 and remained stable until the end of the D 2 O intake period (Extended Data Fig. 2c ). In each donor, deuterium incorporation among tetramer + CD8 T cells increased extremely slowly with time, with an average of 8.2 ± 2.6% newly divided cells after 56 days (Fig. 2e ). This proliferation rate during the memory phase was substantially lower than the antigen-driven proliferation rate seen during the acute post-vaccination stage (Extended Data Fig. 2d, e) . Notably, the cell division rate (0.15 ± 0.045% per day, corresponding to a doubling time of 476 days) for tetramer + memory CD8 T cells in these subjects was comparable to the doubling times calculated by the dilution rate of deuterium enrichment after labelling of effectors during the acute stage (Fig. 2f, Extended Data Fig. 2f ). It is interesting to compare the turnover rate of virus-specific memory CD8 T cells in humans and mice. Earlier work using the mouse LCMV acute infection model has shown that virus-specific memory CD8 T cells divide about every 45 days in mice 13 , whereas human YFV memory CD8 T cells have an intermitotic interval that is more than ten times longer.
Our investigations into the turnover rate of the surviving deuteriumlabelled YFV-specific memory CD8 T cells found that these cells have a long intermitotic phase and divide only once every 485 days on average. However, it is worth noting that the total number of YFV-specific memory CD8 T cells declined at a faster rate, compared to our calculated cell division rate, over the 1-2-year post-vaccination period (Fig. 1b) . The net rate of cell loss was 0.57 ± 0.25% per day (corresponding to a T 1/2 of 123 days) and this can be added to the cell division rate (0.17% per day) to calculate a death rate (rate at which cells disappeared from circulation) of 0.74% per day (corresponding to a T 1/2 of 94 days). Stated differently, the average life-span of the population of YFV-specific CD8 T cells after vaccination is dominated by the rate of net cell loss. It is, however, important to make a distinction between the longevity of the majority of the cells in the starting population, which clearly declines over the first few years post-vaccination, and how the cells that persist are maintained. If our kinetic data had revealed a cell division rate or doubling time comparable to the cell-loss rate (T 1/2 of 123 days), rather than a doubling time of 485 days, after 1 year less than 10%-and after 2 years less than 1%-of the remaining cells in the YFV-specific CD8 T cell population would have retained the deuterium label. By contrast, we found that 90% of the YFV-specific memory CD8 T cells present six months after vaccination were the original labelled cells (Fig. 2c) , and even after 1-2 years these labelled cells represented the majority of the remaining virus-specific memory CD8 T cells (Fig. 1c) . Thus, the YFV-specific CD8 T cells that remain in the population are not only quiescent but have survived for at least 1-2 years, suggesting that there exists a subset of long-lived memory cells.
Previous deuterium labelling studies in humans 12, [14] [15] [16] , investigating the turnover rate of bulk memory CD8 T cell subsets, have reported higher rates of cell proliferation than those we have found when tracking YFV-specific CD8 T cells (Figs 1, 2) . In these earlier studies, the specificity and antigenic history of the T cells being analysed was not known. Without this information, it is difficult to distinguish between the proliferation of T cells recently activated by an antigen and the homeostatic proliferation of long-lived memory cells. It is likely that at least some of the proliferation observed in bulk memory T cell subsets may represent the cycling of recently activated T cells stimulated by antigen, rather than the homeostatic proliferation of memory cells. Our YFV studies not only track CD8 T cells of defined antigen specificity using major histocompatibility complex (MHC) class I tetramers, but also record when these T cells were generated and when the virus was cleared, thus providing more definitive information on human memory T cell life-span and turnover rate.
Tracking effector to memory transition
To investigate the changes that occur as YFV-specific CD8 T cells transition from the naive stage to the effector and memory stages of differentiation, we analysed the transcriptional and epigenetic profiles of naive CD8 T cells and YFV-specific effector (day 14) and memory (days 120-180) cells (Extended Data Fig. 3a-c) . This longitudinal tracking showed that cell cycle and DNA synthesis were prominent among the pathways that were upregulated in the effector transcriptome, which returned to naive levels in the memory CD8 T cells (Extended Data Fig. 4) . A similar pattern was seen with targets of the E2F family of transcription factors that are involved in cell cycle control. Protein-translation-related gene sets were among the most downregulated programs in effector cells, but were re-expressed in memory CD8 T cells. Among the programs that shared the same expression pattern in effector and memory CD8 T cells, immune-related pathways including cytokine signalling featured prominently. Genes with binding sites for LEF1 and NFAT occurred in both the transient effector-specific program and in the programs that were maintained during memory differentiation. To further investigate the transcriptional programming of YFV-specific CD8 T cells, we analysed genome-wide DNA methylation profiles in naive and tetramer + effector and memory CD8 T cells 17, 18 (Extended Data Fig. 3c ). As the YFV-specific CD8 T cells transitioned from the naive to the effector program, over 25,000 regions showed considerable de novo methylation; about 30% of these regions remained methylated in memory cells. In addition to de novo methylation, effector differentiation was associated with demethylation in nearly 8,000 regions, of which over 50% remained demethylated in YFV-specific memory CD8 T cells. This sharing of DNA methylation marks between YFV-specific effector and memory CD8 T cells suggests a lineage relationship between these two populations.
Defining long-lived memory CD8 T cells
As the YFV vaccine induces long-term immunity, we next characterized the memory CD8 T cells that are present several years after vaccination. Phenotypic analysis of tetramer + CD8 T cells isolated from vaccinees a decade after vaccination showed that long-lived YFV-specific memory CD8 T cells express CD45RA and CCR7, which are not expressed by effector YFV-specific CD8 T cells. Long-lived memory CD8 T cells also displayed increased expression of CD28 and CD127, but lacked granzyme B expression, a phenotype that they hold in common with naive CD8 T cells (Fig. 3a) . However, these YFV-specific memory CD8 T cells could be distinguished from naive CD8 T cells by their expression of markers such as CXCR3, CD31, CD11a (also known as LFA-1) and CD95 (Fig. 3b) . A recent study 19 also described YFV-specific long-term memory CD8 T cells with a similar phenotype to that identified in our analysis. Consistent with their quiescent nature, YFV-specific memory CD8 T cells lacked detectable levels of Ki-67 unlike the high levels seen in the YFV-specific effector CD8 T cells (Fig. 3c) . Further characterization of A2-NS4B 214 tetramer + CD8 T cells isolated from vaccinees several years post-vaccination revealed functional features characteristic of antigen-experienced T cells. First, YFV-specific memory CD8 T cells proliferated readily in vitro in response to the A2-NS4B 214 peptide (Fig. 3d) . Second, they showed higher proliferative capacity than naive CD8 T cells in a dose-dependent manner when cultured in vitro with cytokines involved in homeostatic proliferation (IL-7 and IL-15; Fig. 3e , Extended Data Fig. 5 ). Third, these long-lived YFV-specific memory CD8 T cells rapidly produced interferon-γ (IFNγ ) in response to peptide stimulation (Fig. 3h) . By contrast, naive A2-NS4B 214 tetramer + CD8 T cells isolated from unvaccinated donors (Fig. 3f, g ) were not capable of this rapid IFNγ production after peptide stimulation (Fig. 3h) . These results show that although long-lived YFV-specific memory CD8 T cells have a phenotype that resembles naive CD8 T cells in many respects, these resting memory cells are poised to rapidly elaborate effector functions. Next, we performed RNA-seq analysis of YFV tetramer-sorted cells to define the transcriptional program of memory CD8 T cells that persist years after vaccination or clearance of acute YFV infection. Principal component analysis showed that naive YFV effector (day 14) and YFV memory (4-13 years) cells clustered into three distinct groups, but that the transcriptome of the YFV-specific long-lived memory CD8 T cells was more naive-like than effector-like (Fig. 3i) . Consistent with this, many naive-associated genes that were downregulated in effector CD8 T cells were expressed by the long-term YFV-specific memory CD8 T cells, and several transcripts that were upregulated during naive-toeffector CD8 T cell differentiation were downregulated in memory cells Article reSeArcH (Extended Data Fig. 6 ). By comparing these human YFV CD8 T cell signatures with published data 20 from mouse effector and memory CD8 T cells, we found similarities between human and mouse transcriptional programs (Extended Data Fig. 7, Supplementary Table 2 ).
Although the YFV memory cell transcriptional signature was more naive-like than effector-like, it was distinct from naive CD8 T cells (Fig. 3i) . To better understand these differences, we performed pathway analysis using the genes that distinguished between naive and YFV memory CD8 T cells (Fig. 3j) . This analysis showed that T cell receptor and cytokine signalling pathways were enriched in memory cells, suggesting that these long-lived human memory CD8 T cells had acquired an enhanced ability to respond to antigen and cytokines. Interestingly, the toll-like-receptor-mediated signalling pathway was also enriched in memory CD8 T cells. In addition, memory cells displayed increased fatty-acid metabolism, consistent with previous studies showing the importance of this pathway in the survival and self-renewal of memory CD8 T cells 21 .
Epigenetic signature of memory CD8 T cells
YFV-specific effector CD8 T cells express high levels of granzyme B and perforin; memory cells present several years after vaccination do not express these effector molecules (Fig. 4a, c) . This raised the question of whether the DNA methylation of these genes also differed between effector CD8 T cells and long-term memory cells. Consistent with the high level of granzyme B expression in both YFV-specific effector CD8 T cells and memory cells at earlier time points (6-12 months), CpG sites near the granzyme B transcriptional start site were demethylated, compared with those in naive CD8 T cells (Fig. 4a, b) . More interestingly, however, these two CpG sites remained demethylated in the longlived YFV-specific memory CD8 T cells, despite the lack of granzyme B expression in these cells. On performing a similar analysis of a CpG region near the perforin promoter, we found that it was methylated in naive CD8 T cells and nearly completely demethylated in YFV effector CD8 T cells that expressed high levels of perforin (Fig. 4c, d) . Remarkably, this region remained equally demethylated in YFV longterm memory CD8 T cells that no longer expressed perforin. Thus, these data provide compelling evidence that long-lived memory CD8 T cells retain an 'epigenetic memory' of transitioning through a stage of differentiation that involved a transcriptionally permissive granzyme B and perforin locus.
We next investigated transcriptionally open and closed chromatin regions in naive, effector and memory CD8 T cells, using an assay for transposase-accessible chromatin with sequencing (ATAC-seq) 22 . We generated chromatin accessibility maps of naive CD8 T cells and tetramer-sorted YFV-specific effector and memory cells. Principal component analysis of these ATAC-seq data showed that there was a notable similarity between effector and memory CD8 T cells, but that naive CD8 T cells were distinct (Fig. 4e, Extended Data Fig. 8a) . We also compared the various CD8 T cell populations with one another, enumerating the number of differentially accessible sites in each pairwise comparison; this analysis also showed that effector and memory cells were highly similar (Extended Data Fig. 8b) . Together, these ATAC-seq data and the DNA methylation analysis clearly show that YFV-specific memory CD8 T cells retain an epigenetic memory of their effector history. YFV-specific long-lived memory CD8 T cells have a naive-like transcriptome (Fig. 3i, Extended Data Fig. 6 ) but an effector-like open chromatin map, suggesting a mechanism by which memory CD8 T cells are poised to rapidly elaborate effector functions. This is succinctly illustrated by the fact that there is open chromatin near the promoters of the IFNG and GZMB genes in both YFV-specific effector cells and YFV-specific memory CD8 T cells, compared with naive cells (Fig. 4f) . Consistent with this, long-lived quiescent YFV-specific memory CD8 T cells rapidly produced IFNγ upon stimulation with the cognate peptide, whereas naive tetramer + YFV-specific CD8 T cells did not (Fig. 3h) .
YFV-specific memory CD8 T cells express many naive-associated genes that were downregulated in effector CD8 T cells (Fig. 3, Extended  Data Fig. 6 ). Two classic examples of these genes are IL7R (also known as CD127) and BCL2, which are essential for the long-term survival of memory T cells. We used the ATAC-seq data to investigate how the chromatin structure at these two genes changes as naive CD8 T cells differentiate into effector and memory cells. We identified open sites at the transcriptional start site (TSS), as well as immediately upstream and downstream of the TSS, for IL7R in naive CD8 T cells, which express high levels of CD127. However, these sites lost accessibility in YFV-specific effector CD8 T cells, which downregulate CD127, and were open in virus-specific memory cells, which express CD127 (Extended Data  Fig. 9 ). A similar pattern was observed for open chromatin regions in the BCL2 gene; notably, an accessible site downstream of the BCL2 TSS that partially closes in effector CD8 T cells exhibits openness to an even greater extent in virus-specific memory CD8 T cells than in naive cells. These data highlight the unique epigenetic fingerprint of long-lived YFVspecific memory CD8 T cells. These memory cells not only have a poised open chromatin at many genes associated with effector cells, but at the same time they also have open sites at key naive-cell-associated genes.
Discussion
This study addresses fundamental questions about the origin, differentiation, turnover rate and longevity of human memory CD8 T cells generated after an acute viral infection. The long-lived YFV-specific memory CD8 T cells that we have characterized are phenotypically similar to the recently defined human stem-cell-like memory CD8 T cells (T SCM ) 23 (Extended Data Fig. 10 ). These T SCM cells have gained much attention as a subset of memory cells that are distinct from central memory CD8 T cells and that possess superior capabilities for self-renewal, recall responses and pluripotency 23 . It is believed that T SCM cells originate directly from naive CD8 T cells without going through a phase in which they express molecules associated with effector function 24 . Although such a differentiation pathway is plausible, our results support an alternative model in which human memory CD8 T cells have a history of extensive proliferation during the acute phase of infection, and retain epigenetic marks of having expressed effector molecules. In fact, the epigenetic landscape of YFV-specific memory CD8 T cells that are present over a decade after vaccination is much more similar to that of YFV-specific effector cells (day 14) than it is to that of naive CD8 T cells, even though the transcriptional program of these memory cells is more akin to the program of naive cells. Thus, we favour a differentiation model in which memory CD8 T cells originate from a subset of fate-permissive, activated CD8 T cells that not only downregulate effector molecules after antigen has cleared but also re-express naive cell genes such as IL7R, BCL2 and CCR7. The accompanying paper by Youngblood et al. 25 analysing memory CD8 T cells in mice provides additional support for this model of differentiation. The expression of these naive cell genes is critical for cell survival and for homing to lymphoid tissues, and the open poised chromatin at effector genes allows these long-lived circulating memory T cells to elaborate effector function rapidly on re-encounter with the pathogen.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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MethODS
No statistical methods were used to predetermine sample size. The experiments were not randomized, and the investigators were not blinded to allocation during experiments and outcome assessment. Human studies. Institutional review board approval was obtained before donor enrolment and written informed consent was obtained from all donors. Details of donors enrolled in the heavy water study (https://clinicaltrials.gov/, NCT01290055) are provided in Supplementary Table 3 . Data are presented throughout the manu script in days after administration of the YFV-17D vaccine. A single dose of 17D live-attenuated yellow fever vaccine strain (YF-VAX) was administered subcutaneously. Seventy per cent heavy water was obtained from CIL and provided in 50-ml aliquots to donors. Donors drank 50 ml three times daily for the first five days, followed by 50 ml twice daily for the remaining periods of intake. Phlebotomy was performed at indicated time points such that blood draw did not exceed one unit over two months. For long-term memory samples from some donors, leukapheresis was performed to obtain sufficient cell numbers. Flow cytometry, sorting and in vitro experiments. Staining, data acquisition and analysis were done as described previously 8, 26 . For sorting, peripheral blood mononuclear cells (PBMCs) were stained with the YFV-specific tetramers (made in-house) or dextramers (Immudex) and relevant antibodies, washed, and resuspended in sorting buffer (PBS with 1 mM EDTA, 25 mM HEPES and 2% FCS), and populations of interest were isolated in a two-step sort on a BD FACS Aria. For analysis of low frequency tetramer + populations from long-term vaccinees, bead-based tetramer enrichment was used. In our analyses, naive cells were defined as bulk CD45RA +
CCR7
+ CD8 T cells; we isolated YFV-tetramer + CD8 cells at various times post-vaccination and defined 'effector' and 'memory' stages by the time of sampling. The time points (after vaccination) were defined as: effector (day 14-28); memory (day 90 or later); long term memory (3 or more years since vaccine administered).
PBMCs from donors vaccinated at least three years previously were isolated, labelled with CellTrace Violet (CTV) and cultured in complete medium (RPMI with 10% FCS and antibiotics) for nine days in the presence of IL-7 or IL-15 (PeproTech). Additionally, a dose response experiment for IL-7 and IL-15 was done (in five concentrations, from 250 ng ml −1 to 0.05 ng ml
) using PBMC from YFV vaccinees or sorted naive CD8 T cells from unvaccinated donors. Proliferation was assessed by CTV dilution in gated cells. Measurement of deuterium enrichment in cellular DNA and body water. The stable isotope labelling method for measuring cell turnover in small cell numbers has been described previously 9 . In brief, DNA was isolated from FACS-sorted cells and free nucleotides were prepared by enzymatic hydrolysis. Deoxyribose from purine nucleotides was derivatized for GC-MS analysis with pentafluorobenzyl hydroxylamine in acetic acid and acetic anhydride. GC-MS analysis was performed using an Agilent model 5973/6890 GC (Agilent Technologies/Quantum Analytics) in methane NCI mode, with an Agilent DB-17 column (30 m × 250 μ m ID × 25-μ m film thickness) under selected ion monitoring of m/z 435-437. The excess M+ 1 (EM1) mass isotopomer abundance was calculated using unenriched DNA standards to correct for the abundance sensitivity of mass isotopomer ratios. The EM1 value represents the isotope enrichment above natural abundance due to the incorporation of D 2 O into newly synthesized DNA (as deoxyribose). Each analysis was run with two technical replicates (GC-MS injections). Our assay can measure enrichment in cellular DNA reliably from 2,000 cells or fewer, but most of the samples in the present study were in the 10,000-50,000-cell range (typically obtained from 50-100 ml of blood). Calculation of cell division rates. Rate constants of cell proliferation were determined by two methods: (i) by measuring label incorporation in cellular DNA; and (ii) by measuring label die-away in cellular DNA. The label incorporation and dieaway data were converted to rate constants by standard first-order replacement rate kinetic models. These were by intent simple and assumed (i) homogeneity within the pool, and (ii) stable rate constants for birth (p), death (d), and therefore net growth (R), where R = p − d. It can be shown mathematically that if the net cell number is changing exponentially (if total cell numbers vary proportionately to their pool size) and if cells die exponentially, then population-wide birth is also exponential, even though the pool size is not at steady state (for example, where p and d are not equal). Label incorporation method. During heavy water labelling, the cell division rate constant (k) was derived from k = − ln(1 -f) (ref. 9) , in which f represents the fraction of cells that had divided during the observation period, t. In study 2 and study 3, heavy water intake by donors occurred over the course of 14 days and 56 days, respectively; at the end of each labelling period, f was calculated as the ratio of the measured enrichment (EM1) in deoxyribose in sorted cells to the maximum enrichment possible (EM1* ) in deoxyribose if the cells were 100% replaced by newly divided cells under these conditions of heavy water exposure, using the equation f = EM1/EM1* . This maximum EM1* is dependent on 2 H-enrichment in body water (u), and the number of sites on deoxyribose that are susceptible to deuterium labelling from body water, derived previously 3 as EM1* = − 7.7268 × u 2 + 3.5291 × u + 0.0023. In this case, time-averaged 2 H-enrichment in body water was calculated from the trapezoid rule and used as the value of u, to account for temporal variations in body water enrichment during heavy water labelling. For study 1, in which virus-specific CD8 T cells had expanded by over 50-fold based on measured A2-NS4B 214 tetramer + cell counts in circulation (Fig. 1b) , the measured extent of cell expansion was used to estimate the fraction of newly divided cells (f) present at day 14 for the calculation of the cell division rate constant (k). Label die-away method. After heavy water intake had ceased, fractional cell division rates in study 1 and study 2 were calculated as the label incorporation rate constant (k) derived by curve-fitting the isotopic enrichment (EM1) in the virus-specific CD8 T cells measured starting at least four weeks after the last dose of heavy water (Fig. 1c) Figs 1, 2b) . Isotopic enrichment values from blood samples taken between 4 weeks after the last dose of heavy water and day 150 after vaccination were log-transformed and then fit by linear regression to determine the rate constant k in Prism 5 (Graphpad).
Finally, cell division rates (either individual or group averages) were converted to doubling times as T 1/2 = ln(2)/k. The fits were to each individual subject's data, and were very good: the mean R 2 of the die-away fits was 0.85, with standard error of the fits shown in the table (Supplementary  Table 1 ) (0.17 ± 0.04% per day). The analytic coefficient of variation of replicate analyses was approximately 3-5%. The curve fits were for each individual subject; the primary data for each individual are plotted in Figs 1, 2 and shown in Supplementary Table 2 . Expression profiling of naive and YFV-specific CD8 T cells using microarray or RNA-seq. The transcriptional profile of A2-NS4B 214 tetramer + effector (day 14, n = 4) and memory CD8 T cells (4-9 months, n = 6) was investigated using microarrays. Total RNA was isolated from FACS-sorted populations of interest and two-round in vitro transcription amplification and labelling was performed according to the Affymetrix protocol. HG U133 Plus 2.0 Arrays (YFV effector CD8 T cells) or HG U133A arrays (YFV memory CD8 T cells) were used. Only probe sets present on both chips were used for comparing the populations. For analysis, batch effects were adjusted using ComBat (an empirical Bayes method) and then a cluster affinity search technique was performed to identify expression patterns. RNA-seq analysis of naive and YFV-tetramer + effector (day 14) and long-term memory (> 3 years) CD8 T cells was done. Library preparation and sequencing for RNA-seq was performed by Hudson Alpha, and sequencing was done using an Illumina Hiseq 2000. Transcript-level expression analysis was performed in R using the Deseq2 package. Genes from the transient or maintained clusters identified in Extended Data Fig. 4 were analysed using MSigDB to identify Reactome pathways and transcription factors associated with each expression pattern. Comparison of mouse versus human CD8 T cell populations. We compared the RNA-seq data from YFV-tetramer + CD8 T cells to previously reported microarray data from mouse CD8 T cell populations. We identified five published datasets 20, [27] [28] [29] [30] pertaining to mouse memory CD8 T cells (GSE10239, naive versus memory; GSE9650 naive versus memory; naive versus memory in ref. 20 ; GSE21360, naive versus primary memory; GSE41867, naive versus day 30 memory), and three describing mouse effector CD8 T cells (GSE41867, naive versus day 8; GSE9650 naive versus day 8; naive versus effector in ref. 20) . The gene signatures for each dataset were generated by selecting the top 400 up-and downregulated genes. We then performed gene set enrichment analysis (GSEA) to determine the degree of overlap of human YFV-specific CD8 T cells with the mouse CD8 signatures. Using this analysis, most mouse effector and memory T cell gene sets had strongly positive enrichment scores with respect to human YFV-specific CD8 T cells. Further, upregulated genes generally had higher enrichment scores than the downregulated genes.
We next used the GSEA leading edge analysis tool to identify genes that were regulated in common in the YFV effector and memory phenotypes, and which overlapped with genes in the corresponding mouse signatures. In the effector cells, this included the homing molecules CXCR3 and CCR5, the cytotoxic molecules PRF1, IFNG and GZMB, and the transcription factor ID2. By comparison, the downregulated genes had lower enrichment scores and fewer genes that overlapped between the human and mouse datasets. However, several important surface receptors, such as CD127 and IL6ST, and transcription factors, such as MYC, TCF7, ID3 and LEF1, were conserved across the datasets. In memory cells, many of the genes that were common in the effector subset continued to be expressed differentially in both mouse and human memory datasets. This includes the effector molecules PRF1 and GZMB, the cytokine and chemokine receptors IL18R1, CCR5 and CCR2, and the transcription factors ID3, LEF1 and MYB. Bisulfite sequencing methylation analysis. By deaminating cytosine using bisulfite treatment, we determined the frequency of cytosine methylation of
